Page 1 - Y. Vascular biology
P. 1

Expression and function of an IL-12R type in


           the human aortic smooth muscle cells

                                        Heesu Lee, Sang Won Kang
        1 Department of Life Science, Ewha Womans University, Seoul 03760, Republic of Korea;

                  BACKGROUND                                                   AIM

  VSMCs are known to play important roles throughout all stages IL12Rβ2 expression in immune cells is well known, but its
  of atherosclerosis. Especially, VSMCs proliferation and migration expression in vascular cells is unclear. Because endothelial cells
  are important for the progression of arteriosclerosis. Also, are almost denuded or detached in the balloon injury model,
  VSMCs proliferation contributes to in-stent restenosis. Balloon VSMCs are considered a source of IL12Rβ2, but it is still
  injury model is a model that mimics this phenomenon. In the uncertain. Therefore, this data shows whether VSMCs express
  previous study, proteomics was performed in the balloon-injured IL12Rβ2 and how IL12Rβ2 expression level increases
  rat carotid artery to identify signaling molecules organizing the         METHOD
  VSMC hyperplasia. The differential proteomics analysis revealed
  the protein that the expressions are changed within 3 days post  -  Cell culture and Transfection
  injury. One of which was Interleukin-12 receptor β2 (IL12Rβ2). -  Quantitative real time PCR
  IL12Rβ2 expression increased during 7 days post injury. IL12Rβ2  -  Reverse transcription-PCR
  is one of Interleukin-12 family receptor, and its ligand is  -  Immunoprecipitation(IP) and Immunoblotting (IB)
  Interleukin 12 (IL-12) or Interleukin 35 (IL-35).
                                                 RESULTS                               293T        293T
                      VCAM-1 mRNA expression (Fold chnage)  6  IL12Rb2 mRNA expression (Fold change)  IB : Flag  IB : Flag
                                                  pre-treated
                                                  si-IL12Rb2
                                                                                                  Vector
                                                                                      Vector
           HASMC      10 8                     8 6  si-CON                         siRNA :  control IL12Rb2  IL12Rb2 IL12Rb2  siRNA :  control IL12Rb2  IL12Rb2 IL12Rb2
  TNF-α (10ng/mL) :  0    3   5  10  30  (min)                                     DNA :       DNA :
       IκB            4                        4                                IP : Flag  IL12Rb2  IP : IL12Rb2  IL12Rb2
      Tubulin         2                        2                                   Flag        Flag
                      0
                   TNF-α (10ng/mL) :  0  4  8  12  24  (hours)  0                IB  IL12Rb2  IB  IL12Rb2
                                             IFN-γ :  -  +   +                     Tubulin  HASMC  Tubulin  HASMC
                                     Figure 2. IL12Rβ2 mRNA expression in HASMCs is upregulated by IFN-γ.
                      VCAM-1 mRNA expression (Fold chnage)  (50ng/ml) for 48 hours.            IB : Flag
                       6
                                     IL12Rβ2 mRNA expression level was measured by qRT-PCR. (n=3) (**P<0.005).
           HASMC       5             (A) Time course of IL12Rβ2 mRNA expression following treatment with indicated cytokines.  siRNA :  control  IL12Rb2  siRNA :  control  IL12Rb2
                                     (B) IL12Rβ2 mRNA expression level was measured by qRT-PCR. HASMCs were transfected
  IL-1β (10ng/mL) :  0   5  10  15  30  60 (min)  4  with siIL12Rβ2 using Lipofectamine® RNAiMAX Reagent for 6 hours and then treated with IFN-γ  Virus :  Vector  IL12Rb2  IL12Rb2  Virus :  Vector  IL12Rb2  IL12Rb2
      IκB              3                              Full length primer  Primer 1  Primer 2  IP : Flag  IB : Flag  IP : IL12Rb2
                                             Exon : 1
     Tubulin           2 1                  variant 1  2 3  4 5 6 7 8  9  10 11 12 13 14 15 16  IL12Rb2  IL12Rb2
                                                                                               Flag
                                                                                   Flag
                                            variant 2
                       0
                  IL-1β (10ng/mL) :  0  4  8  12  24  (hours)  variant 3         IB  IL12Rb2  IB  IL12Rb2
                                            variant 4                              Tubulin     Tubulin
           HASMC       5     *              variant 5                     Figure 4. Exogenous IL12Rβ2 expression on 293T and HASMCs.
                                            variant 6
                                                                          293T cells were overexpressed with the empty vector (pQ) or vector encoding human
  IFN-γ (50ng/mL) :  0  5  10  15  30  60 (min)  4  variant 7             IL12Rβ2 with Flag tag using turbofect reagent for 24 hours and then transfected with
     pSTAT1                 *                U937 HASMC                   siIL12Rβ2 using Lipojet reagent for 48 hours. The immunoprecipitated (A) Flag or (B)
     (Y701)           T-bet mRNA expression (Fold chnage) 6 3  **  IFN-γ : -  -  +  U937  U937  IL12Rβ2 proteins were subjected to the immunoblotting.
                                                                          HASMCs were overexpressed with human IL12Rβ2 with Flag tag encoding retrovirus for 24
     STAT1             2                 IL12Rb2    colony :  2  primer 1 18  (bp) colony :  2  primer 2 18  hour and then transfected with siIL12Rβ2 using Lipofectamine®RNAiMAX reagent for 48
                                                         13
                                                                  13
                                                                          hours. The immunoprecipitated (C) Flag or (D) IL12Rβ2 proteins were subjected to the
     Tubulin           1 0                β-actin  (bp) 500   400         immunoblotting.  HASMC    HASMC
                                                    400
                                                              300
                                                              200
                                                    300
                   IFN-γ (50ng/mL) :  0  24  48  72  (hours)  HASMC+IFN-γ  HASMC  virus :  vec  IL12Rb2-Flag  Virus :  vec  IL12Rb2-Flag
   Figure 1. Effect of pro-inflammatory cytokines on HASMCs  primer 1  siRNA : control IL12Rb2  PDGF-BB :  0 5 10 30  0 5 10 30 (min)  IL-12:  0 5 10 30  0 5 10 30  (min)
   HASMCs were treated with (A) TNF-α (10ng/ml) or (B) IL-1β (10ng/ml) for the indicated  colony : 4  8 13 14 16  pSTAT4
   time. IκB and tubulin were analyzed by immunoblotting. Tubulin is loading control.  (bp) 500  pTyr  (Y693)
   (C) After the serum starvation, HASMCs were treated with IFN-γ (50ng/ml) for the  400
                                            300
   indicated time. STAT1, phospho-STAT1, and tubulin were analyzed by immunoblotting.  IL12Rb2(G465D)  IL12Rb2(G465D)  PDGFR  STAT4
   Tubulin is loading control.
   The fold change of VCAM-1 mRNA levels in (D) TNF-α (10ng/ml) or (E) IL-β (10ng/ml) 0, 4,  HASMC+IFN-γ  Vector  IL12Rb2  IL12Rb2  pErk 1/2  Flag
   8, 12, 24 hours treated HASMCs. Time course of mRNA expression measured by qRT-  primer 2  Virus :
   PCR.                                     colony : 4  8 13 14 16                           Tubulin
   (F) The fold change of T-bet mRNA levels in IFN-γ (50ng/ml) 0, 24, 48, 72 hours treated  (bp)  400  IL12Rb2  Erk 2
   HASMCs. Time course of mRNA expression measured by qRT-PCR. (n=3) (*P<0.05,  300
                                            200
   **P<0.005).                                            Tubulin            Flag                   HASMC
                                                                                              Virus :  vec  IL12Rb2-Flag
                                                                            IL12Rb2          pSTAT1   0 5 10 30  (min)
                                                                                              IL-35 : 0 5 10 30
   IL12Rb2 mRNA expression (Fold chnage)  10 8 6 4  TNFα  IL12Rb2 mRNA expression (Fold chnage)  10 8 6 4  (A) The transcription variant and isoform of IL12Rβ2.  Figure 5. IL12Rb2 affects signaling in HASMC.  STAT1
    12
                      12
                                                                            Tubulin
                                                                                             (Y701)
                                      Figure 3. IL12Rβ2 transcription variant 1 is expressed in HASMCs
                           **
       IFNγ
       IL12
       IL1β
                                      (B) RT-PCR analysis of IL12Rβ2 mRNA expressed in U937, HASMCs, and IFN-γ (50ng/ml)
                                      48hr treated HASMCs. β-actin is an endogenous control gene.
                                      Cloning of IL12Rβ2 full length PCR product in (C) U937 and (D) IFN-γ treated HASMCs was
                                                                                             Flag
                                      performed. Colony PCR to separate the IL12Rβ2 transcriptions variant based on primer from
                                                                                             Tubulin
                                      (A).
                                      (E) Sequencing data of IL12Rβ2 full length in IFN-γ treated HASMCs.
                       2
    2
                                      retrovirus for 24 hour and then transfected with siIL12Rβ2 using Lipofectamine® RNAiMAX
                                                                          hour and then, after starvation, treated with (A) PDGF-BB (25ng/ml), (B) IL-12 (10ng/ml) or (C)
    0
                       0
                                      Reagent for 48 hours. The protein expression was detected by immunoblotting.
                                                                          IL-35 (10ng/ml) for the times indicated. pTyr, PDGFR, pERK, ERK2, pSTAT4, STAT4,
     0  24  48  72  (hours) IFN-γ (50ng/mL) :  0  24  48  72  (hours)  (F) HASMCs were overexpressed with IL12Rβ2 wild type or variant G465D encoding  HASMCs were overexpressed with human IL12Rb2 with Flag tag encoding retrovirus for 24
                                                                          pSTAT1, STAT1, Flag, IL12Rβ2 and tubulin were analyzed by immunoblotting. Tubulin is
                                                                          loading control.
                   CONCLUSION                                           REFERENCES
  Pro-inflammatory cytokines promote proliferation in VSMCs, [1]. Ross, R. and J.A. Glomset, Atherosclerosis and the arterial
  among them,, IFN-γ increases the IL12Rβ2 mRNA expression smooth muscle cell: Proliferation of smooth muscle is a key event
  level in VSMCs. The IL12Rβ2 mRNA increased by IFN-γ is not a in the genesis of the lesions of atherosclerosis. Science, 1973.
  non-coding mRNA but a transcription variant 1 of IL12Rβ2. 180(4093): p. 1332-9.
  Overexpressed IL12Rβ2 was not affect PDGF and IL-12 signal [2] Kang, D.H., et al., Vascular Proteomics Reveal Novel Proteins
  but increase IL-35 signal in VSMCs.                   Involved in SMC Phenotypic Change: OLR1 as a SMC Receptor
  Because IL-35 has been reported to be involved in the adhesion Regulating Proliferation and Inflammatory Response. PLoS One,
  molecules expression and proliferation in vascular cells, it is 2015. 10(8): p. e0133845.
  necessary to confirm that the overexpressed IL12Rβ2 contribute [3] Vignali, D.A. and V.K. Kuchroo, IL-12 family cytokines:
  to affecting the adhesion molecules expression and proliferation immunological playmakers. Nat Immunol, 2012. 13(8): p. 722-8.
  of VSMCs via cell assay. Therefore, this study suggest a novel [4] de Paus, R.A., et al., Differential expression and function of
  role of IL12Rβ2 in VSMCs and proposes IL12Rβ2 may be human IL-12Rbeta2 polymorphic variants. Mol Immunol, 2013.
  associated with VSMC hyperplasia.                     56(4): p. 380-9.
   1   2   3   4   5   6